Biotech · Private company
Cancer Prevention Pharmaceuticals, Inc.
Track this companyFree. Adds Cancer Prevention Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- EflornithinePhase 3 · Familial Adenomatous PolyposisClinicalTrials.gov · fetched Nov 12, 2026
- Sulindac 150 MGPhase 3 · Familial Adenomatous PolyposisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- TArgeting Type 1 Diabetes Using POLyamines (TADPOL)PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 14, 2023ClinicalTrials.gov NCT05594563 · fetched Nov 12, 2026
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)PHASE3 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01483144 · fetched Nov 12, 2026
- Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With EtoposidePHASE1 · COMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT01059071 · fetched Nov 12, 2026